„Humoral“ Immunity and Immune Homeostasis in Atherosclerosis
23.11.2022, 17:00 - 17:45 Uhr
Prof. Dr. Christoph Binder
Department of Laboratory Medicine Medical University of Vienna & Center for Molecular Medicine of the Austrian Academy of Sciences
Macromolecular strategies for enhancing immunotherapy responses to treat cardiovascular diseases
06.09.2022, 17:00 - 17:45 Uhr
Julius Maximilian University Würzburg
Unser Clusterkonzept wurde von einer unabhängigen und hochrangigen Expertenjury als Zukunftscluster ausgewählt. Für die erste Umsetzungsphase erhält curATime eine Fördersumme von 15 Mio €.
Inflammation of the heart: Mechanism and therapeutic options
21.07.2022, 16:00 – 16:45 Uhr
Prof. Dr. med. Florian Leuschner
Heidelberg University Hospital
Atherothrombosis: the impact of clotting proteases
21.06.2022 17:30 - 18:15 Uhr
Prof. Hugo ten Cate
CARIM, Maastricht University Medical Center+
RNA therapeutics in cardiovascular disease
12.04.2022, 17:00 - 18:00 Uhr
Prof. Dr. Stefanie Dimmeler
Goethe- University, Frankfurt
Institute of Cardiovascular Regeneration, Centre for Molecular Medicine
Chemometrics strategies and tools in Precision Medicine
23.03.2022 17:30 - 18:15 Uhr
Prof. Johan Trygg
Departmentof Chemistry, Umeå University, Umeå, Sweden
Corporate Research, Sartorius, Umeå, Sweden
Artificial CRISPR, an AI based approach to predict signature drug response from multi-omics datasets
22.03.2022, 17:30 - 18:15 Uhr
Prof. Dr. Jürgen Scheele
Chief Medical Officer Innoplexus AG
Advancing Robust Signal Processing and Statistical Learning for Biomedical Applications
15.02.2022, 17:30 - 18:15 Uhr
Prof. Dr.-Ing. Abdelhak Zoubir
Signal Processing Group, Technical University of Darmstadt
Human gut microbiota variation in health and disease
02.02.2022, 17:00 – 17:45 Uhr
Laboratory of Molecular Bacteriology (Rega Institute), KU Leuven, Belgium
Zeige 41 bis 50 von 52 Ergebnissen
